Luis Borges

Luis Borges

Company: Century Therapeutics

Job title: Chief Scientific Officer


Leveraging Orthotopic Tumor Xenograft Models to Develop iPSC-Derived Cell Therapies Against Glioblastoma Multiforme 9:30 am

Century’s iPSC NK and T cell platforms; harnessing the power of induced pluripotent stem cells to develop novel allogeneic cell therapies against multiple cancer types, including glioblastoma multiforme (GBM) Introducing GBM clinical candidate selection using patient-derived cell xenografts implanted into the brain of recipient mice Evaluation of the efficacy and local & systemic toxicities of…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.